Olin (OLN) Q2 2026 earnings review
EBITDA Rebounds, But Outages and Litigation Dilute the Merger Excitement
Olin delivered a substantial sequential rebound, generating $191.3M in Adjusted EBITDA (up from $86.2M in Q1), signaling that its structural Beyond250 cost actions and pricing power are taking hold. However, bottom-line results remained mired in a net loss (-$13.3M) due to a costly unplanned outage at the Freeport vinyls facility and transaction costs related to the blockbuster announcement of a merger of equals with Huntsman Corporation. The Epoxy segment was the standout, reversing a year-long string of heavy losses to post a profit. While Q3 guidance of $160M-$200M EBITDA points to a stable trough exit, debt levels remain a critical concern, with Net Debt to EBITDA sitting at an elevated 5.0x.
🐂 Bull Case
After multiple quarters of steep losses, Epoxy sales jumped 27% YoY and earnings flipped back to positive ($16.0M), proving that internal cost re-alignments in Europe and price hikes are effectively expanding margins.
The OlinHuntsman merger of equals fundamentally changes the long-term investment narrative, creating a chemical giant with massive potential for cost synergies and footprint optimization beginning in 2027.
🐻 Bear Case
The $40.1M EBITDA penalty from the unplanned Freeport VCM plant outage directly undermines management's prior claims that the Beyond250 program was resolving historical site reliability issues.
Working capital increased by $183M in the first half, heavily driven by $93M in Shintech litigation payments. With another $100M due in H2, Net Debt to EBITDA has swelled to a restrictive 5.0x.
⚖️ Verdict: ⚪
Neutral. The sequential core operational improvement and Epoxy's return to profitability are highly encouraging. However, recurring plant outages, heavy legacy litigation cash drains, and the distraction risk of a massive upcoming integration keep a lid on the near-term bull case.
Key Themes
The OlinHuntsman Merger of Equals
Olin and Huntsman have agreed to an all-stock merger to form OlinHuntsman Corporation, targeted to close in H1 2027. This shifts the strategic narrative from "managing a cyclical trough" to "complex integration and synergy realization." Q2 recognized $10.6M in acquisition-related costs, a figure that will only grow as the closing date approaches.
Freeport Outage Contradicts Positive Narrative
While management touted the structural benefits of the 'Beyond250' cost program, operational execution tripped them up again. An unplanned shutdown of the vinyl chloride monomer (VCM) plant in Freeport wiped out $40.1M in Q2 adjusted EBITDA. With the plant currently running at reduced rates, an additional $20M penalty is guided for Q3, raising questions about deferred maintenance catching up to the company.
Epoxy Margin Expansion is Reversing the Downtrend
Reversing. The Epoxy segment is officially out of the woods. After reporting deep losses in the prior four quarters (including a -$23.7M loss in 25Q2), the segment posted a $16.0M profit in 26Q2. This was driven by a 27.4% YoY surge in revenue, improved global product margins, and the flow-through of aggressive price hikes enacted earlier in the year despite weak European macro demand.
Winchester Strength Despite Inflation
Stable. The Winchester segment grew sales by 11.8% YoY to $500.3M and expanded earnings to $28.1M. This confirms that the aggressive pricing actions taken to offset spiking commodity metal costs (copper, brass) are sticking, while the strategic pivot towards modernizing defense manufacturing (including the Next Generation Squad Weapon facility at Lake City) is delivering reliable military project revenue.
CAPV Segment Lags Due to JV Conclusion and Outages
Decelerating. The Chlor Alkali Products and Vinyls (CAPV) segment was the primary laggard. Sales plunged 16.3% YoY to $819.5M, and earnings contracted 17.7% to $53.4M. Beyond the Freeport outage, the volume decline was heavily driven by the dissolution of the Blue Water Alliance trading joint venture, which concluded at the end of 2025.
Litigation Drain Pressuring Balance Sheet
The financial statements reveal a massive drag on working capital: Olin paid $93M in Q2 to resolve legacy Shintech litigation matters and explicitly stated they expect to pay the remaining ~$100M in the second half of 2026. This limits the company's ability to organically deleverage ahead of the Huntsman merger.
Macro Volatility and Global Pricing Shifts
The broader global environment remains highly volatile, but Olin has been able to extract higher pricing for caustic soda and ethylene dichloride (EDC) in 26Q2. Geopolitical and shipping disruptions continue to benefit Olin's US Gulf Coast asset footprint relative to overseas competitors, though Q3 guidance warns of weaker EDC pricing ahead.
Other KPIs
Reversing. Leverage continues to climb in the wrong direction, moving from 4.1x at the end of 2025 to 5.0x at the end of 26Q2. With $177.4M in cash against over $3.0B in long-term debt, the balance sheet flexibility is highly constrained right when the company is entering a massive M&A integration phase.
Decelerating cash conversion. The heavy build is attributed to both normal seasonal patterns (which should liquidate in H2) and the punitive Shintech litigation payouts. Operating cash flow will need a massive H2 reversal to align with management's historical cash-generation targets.
Guidance
Stable. The midpoint of $180M indicates a slight deceleration from Q2's $191.3M actuals. Management explicitly calls out that expected stronger caustic soda volumes will be fully offset by weaker EDC pricing and the lingering $20M penalty from the Freeport VCM facility running at reduced rates.
Key Questions
Huntsman Merger Synergies
Given the current focus on the Beyond250 internal cost program, how will the integration of Huntsman impact or overlap with existing footprint rationalization efforts? What is the preliminary estimate for overlapping SG&A?
Freeport Root Cause
The Freeport VCM plant just had a major triennial turnaround completed earlier this year. Why did a separate unplanned outage occur so soon after, and what does this say about the baseline reliability of the Gulf Coast assets?
EDC Pricing Dynamics
Guidance points to weaker ethylene dichloride (EDC) pricing in Q3, offsetting caustic strength. Is this weakness driven by a localized US dynamic, or are we seeing a resurgence of lower-cost Asian exports circumventing recent supply chain hurdles?
Path to Deleveraging
With Net Debt to EBITDA at 5.0x and another $100M in litigation payments pending in H2, how does management plan to achieve the sub-2.0x target profile before the Huntsman transaction closes in H1 2027?